13F filer · CIK 1167557 ↗

AQR Capital

You are looking at Q4 2021. See the latest, Q2 2026 →

Reported value

$55.17B

+2.3% on the quarter before

Positions

2,188

135 new · 181 sold out

Top 10

17.1%

of the value

Est. gain

+$4.44B

on stocks held all quarter

Est. return

+9.5%

on those stocks since Q3 2021

Filed

Feb 14, 2022

On SEC EDGAR ↗

Positions as of Dec 31, 2021, from AQR Capital's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 27% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2021. Striped tiles are options.

Apple3.5%Microsoft3.5%Alphabet1.7%Amazon1.6%TSMC1.4%Meta1.2%
Thermo Fisher Scientific Inc1.1%
Alphabet1.0%
Procter And Gamble Co0.9%
Johnson & Johnson0.9%
Cisco0.8%Tesla0.8%
Home Depot Inc0.8%
Unitedhealth Group Inc0.8%
Nvidia0.8%
Accenture Plc Ireland0.7%
Pfizer Inc0.7%
Jpmorgan Chase & Co0.7%
Allstate Corp0.7%
Texas Instruments0.7%
Walmart Inc0.6%
Costco Whsl Corp New0.6%
Intel0.6%
Pepsico Inc0.6%

Largest buys

Since Q3 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Tesla~$161.3MAdded · 0.4% → 0.8%+152,602 shares
  2. Conocophillips~$125.2MAdded · 0.1% → 0.4%+1,739,891 shares
  3. Chevron Corp New~$115.0MAdded · 0.1% → 0.3%+980,846 shares
  4. Regeneron Pharmaceuticals~$109.6MAdded · 0.3% → 0.5%+173,586 shares
  5. NRG Energy~$91.5MAdded · 0.1% → 0.2%+2,125,059 shares
  6. Pfizer Inc~$70.3MAdded · 0.5% → 0.7%+1,190,989 shares
  7. Motorola Solutions Inc~$62.6MAdded · 0.1% → 0.2%+231,033 shares
  8. AT&T~$55.9MAdded · 0.1% → 0.2%+2,272,001 shares
  9. Walgreens Boots Alliance Inc~$51.8MAdded · 0.1% → 0.2%+998,070 shares
  10. Exxon Mobil Corp~$47.7MAdded · 0.2% → 0.3%+780,201 shares

Largest sells

Since Q3 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Apple~$423.0MCut · 3.5% → 3.5%−2,382,310 shares
  2. Meta~$197.3MCut · 1.6% → 1.2%−586,505 shares
  3. Target Corp~$180.3MCut · 0.9% → 0.5%−784,060 shares
  4. Anthem Inc~$153.5MCut · 0.6% → 0.4%−331,133 shares
  5. Thermo Fisher Scientific Inc~$111.8MCut · 1.2% → 1.1%−167,591 shares
  6. Qualcomm~$108.9MCut · 0.3% → 0.3%−595,416 shares
  7. Humana Inc~$107.3MCut · 0.2% → 0.1%−231,395 shares
  8. Amazon~$106.2MCut · 1.8% → 1.6%−31,843 shares
  9. Hp Inc~$104.7MCut · 0.3% → 0.2%−2,779,377 shares
  10. Dollar Tree Inc~$96.5MCut · 0.1% → 0.0%−687,307 shares

Holdings

As of Dec 31, 2021. Changes are in shares against Sep 30, 2021, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
AppleCOM · shares −18% · price +25.5%3.5%$1.96B+$397.3M
MicrosoftCOM · shares −4.1% · price +19.3%3.5%$1.95B+$316.2M
AlphabetCAP STK CL A · shares −8.9% · price +8.4%1.7%$943.1M+$72.8M
AmazonCOM · shares −11% · price +1.5%1.6%$876.1M+$13.0M
TSMCSPONSORED ADS · shares −3.3% · price +7.8%1.4%$792.2M+$57.0M
MetaCL A · shares −23% · price −0.9%1.2%$676.5M−$6.1M
Thermo Fisher Scientific IncCOM · shares −15% · price +16.8%1.1%$631.3M+$90.7M
AlphabetCAP STK CL C · shares −9.8% · price +8.6%0.99%$547.3M+$43.2M
Procter And Gamble CoCOM · shares −15% · price +16.3%0.94%$519.2M+$72.8M
Johnson & JohnsonCOM · shares −2.0% · price +5.9%0.93%$510.8M+$28.6M
CiscoCOM · shares −5.5% · price +16.4%0.79%$438.2M+$61.8M
TeslaCOM · shares +62% · price +36.3%0.76%$419.6M+$68.8M
Home Depot IncCOM · shares −2.1% · price +25.1%0.76%$419.1M+$84.2M
Unitedhealth Group IncCOM · shares −5.2% · price +28.5%0.76%$417.1M+$92.5M
NvidiaCOM · shares −0.04% · price +42.0%0.76%$416.9M+$123.3M
Accenture Plc IrelandSHS CLASS A · shares −16% · price +29.1%0.73%$404.9M+$91.2M
Pfizer IncCOM · shares +21% · price +37.3%0.73%$404.2M+$90.7M
Jpmorgan Chase & CoCOM · shares −5.8% · price −3.3%0.70%$388.7M−$13.1M
Allstate CorpCOM · shares +8.4% · price −7.6%0.68%$377.7M−$28.6M
Texas InstrumentsCOM · shares −14% · price −1.9%0.67%$369.3M−$7.3M
Walmart IncCOM · shares −16% · price +2.6%0.65%$358.4M+$8.9M
Costco Whsl Corp NewCOM · shares −5.7% · price +24.7%0.63%$348.0M+$68.9M
IntelCOM · shares −14% · price −3.3%0.60%$332.4M−$11.5M
Pepsico IncCOM · shares −5.1% · price +14.5%0.58%$317.5M+$40.2M
Arrow ElectronicsCOM · shares −9.6% · price +19.6%0.56%$308.1M+$50.4M
Total · 2,188 positions100%$55.17B+$4.44B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2021 to Q4 2021: 2,049 stocks held throughout, up $4.44B (+9.5%).

  1. Apple+$397.3M+25%
  2. Microsoft+$316.2M+19%
  3. Nvidia+$123.3M+42%
  4. Unitedhealth Group Inc+$92.5M+29%
  5. Accenture Plc Ireland+$91.2M+29%
  6. PDD Holdings−$24.0M−36%
  7. Allstate Corp−$28.6M−8%
  8. Medtronic Plc−$29.9M−17%
  9. Dell Technologies Inc−$39.3M−46%
  10. Moderna Inc−$56.8M−34%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 8 splits read into the share counts.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$400.00B$200.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$286.85B+31%SEC ↗
Q1 2026$218.37B+15%SEC ↗
Q4 2025$190.63B+22%SEC ↗
Q3 2025$156.00B+29%SEC ↗
Q2 2025$120.88B+25%SEC ↗
Q1 2025$97.07B+25%SEC ↗
Q4 2024$77.63B+7%SEC ↗
Q3 2024$72.44B+11%SEC ↗
Q2 2024$65.24B+11%SEC ↗
Q1 2024$58.73B+11%SEC ↗
Q4 2023$53.13B+10%SEC ↗
Q3 2023$48.43B+3%SEC ↗
Q2 2023$47.05B+3%SEC ↗
Q1 2023$45.56B+4%SEC ↗
Q4 2022$43.89B+7%SEC ↗
Q3 2022$41.02B−7%SEC ↗
Q2 2022$44.25B−16%SEC ↗
Q1 2022$52.69B−4%SEC ↗
Q4 2021$55.17B+2%SEC ↗
Q3 2021$53.94B−7%SEC ↗
Q2 2021$57.80B−5%SEC ↗
Q1 2021$61.14B+8%SEC ↗
Q4 2020$56.41B−5%SEC ↗
Q3 2020$59.16B−4%SEC ↗
Q2 2020$61.82B+4%SEC ↗
Q1 2020$59.45B−32%SEC ↗
Q4 2019$87.96B+4%SEC ↗
Q3 2019$84.91B−5%SEC ↗
Q2 2019$89.62B−5%SEC ↗
Q1 2019$94.26B+9%SEC ↗
Q4 2018$86.30B−17%SEC ↗
Q3 2018$104.52B+5%SEC ↗
Q2 2018$99.28B+7%SEC ↗
Q1 2018$92.73B−3%SEC ↗
Q4 2017$95.29B+14%SEC ↗
Q3 2017$83.80B+11%SEC ↗
Q2 2017$75.57B+0%SEC ↗
Q1 2017$75.24B+4%SEC ↗
Q4 2016$72.48B+11%SEC ↗
Q3 2016$65.33B+15%SEC ↗
Q2 2016$56.67B+2%SEC ↗
Q1 2016$55.59BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.